These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7881868)
1. Reduced drug resistance in a multidrug resistant cell line by 5,8,11,14-eicosatetraynoic acid. Anderson KM; Harris JE Res Commun Mol Pathol Pharmacol; 1994 Nov; 86(2):195-203. PubMed ID: 7881868 [TBL] [Abstract][Full Text] [Related]
2. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells. Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169 [TBL] [Abstract][Full Text] [Related]
3. Characterization of 2-chloro-N10-substituted phenoxazines for reversing multidrug resistance in cancer cells. Thimmaiah KN; Jayashree BS; Germain GS; Houghton PJ; Horton JK Oncol Res; 1998; 10(1):29-41. PubMed ID: 9613455 [TBL] [Abstract][Full Text] [Related]
4. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
5. Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux. Brouty-Boyé D; Kolonias D; Wu CJ; Savaraj N; Lampidis TJ Cancer Res; 1995 Apr; 55(8):1633-8. PubMed ID: 7712466 [TBL] [Abstract][Full Text] [Related]
6. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
7. DiOC2(3) is not a substrate for multidrug resistance protein (MRP)-mediated drug efflux. Minderman H; Vanhoefer U; Toth K; Yin MB; Minderman MD; Wrzosek C; Slovak ML; Rustum YM Cytometry; 1996 Sep; 25(1):14-20. PubMed ID: 8875050 [TBL] [Abstract][Full Text] [Related]
8. Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Lautier D; Canitrot Y; Salmon JM Anticancer Res; 1994; 14(6B):2589-95. PubMed ID: 7872686 [TBL] [Abstract][Full Text] [Related]
9. Rhodamine 123: is it an appropriate dye to study P-glycoprotein activity in adriamycin-resistant K562 cells? Denis-Gay M; Petit JM; Ratinaud MH Anticancer Res; 1995; 15(1):121-6. PubMed ID: 7733620 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of U937 eicosanoid and DNA synthesis by 5,8,11,14-eicosatetraynoic acid, an inhibitor of arachidonic acid metabolism and its partial reversal by leukotriene C4. Ondrey F; Harris JE; Anderson KM Cancer Res; 1989 Mar; 49(5):1138-42. PubMed ID: 2492901 [TBL] [Abstract][Full Text] [Related]
11. Novel phosphonium salts display in vitro and in vivo cytotoxic activity against human ovarian cancer cell lines. Manetta A; Gamboa G; Nasseri A; Podnos YD; Emma D; Dorion G; Rawlings L; Carpenter PM; Bustamante A; Patel J; Rideout D Gynecol Oncol; 1996 Feb; 60(2):203-12. PubMed ID: 8631539 [TBL] [Abstract][Full Text] [Related]
12. Eicosatetraynoic acid (ETYA), a non-metabolizable analogue of arachidonic acid, blocks the fast-inactivating potassium current of rat pituitary melanotrophs. Kehl SJ Can J Physiol Pharmacol; 2001 Apr; 79(4):338-45. PubMed ID: 11332511 [TBL] [Abstract][Full Text] [Related]
13. Liposome composition is important for retention of liposomal rhodamine in P-glycoprotein-overexpressing cancer cells. Kang DI; Kang HK; Gwak HS; Han HK; Lim SJ Drug Deliv; 2009 Jul; 16(5):261-7. PubMed ID: 19538007 [TBL] [Abstract][Full Text] [Related]
14. Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen. Lee JS; Paull K; Alvarez M; Hose C; Monks A; Grever M; Fojo AT; Bates SE Mol Pharmacol; 1994 Oct; 46(4):627-38. PubMed ID: 7969041 [TBL] [Abstract][Full Text] [Related]